DocGo Inc. (NASDAQ:DCGO) Given Consensus Recommendation of “Buy” by Brokerages

DocGo Inc. (NASDAQ:DCGOGet Free Report) has been assigned a consensus recommendation of “Buy” from the five research firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $6.10.

A number of equities research analysts have recently weighed in on DCGO shares. Needham & Company LLC restated a “buy” rating and issued a $7.00 price target on shares of DocGo in a research note on Thursday, August 8th. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research report on Friday, September 20th.

Read Our Latest Research Report on DCGO

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in DCGO. nVerses Capital LLC increased its position in DocGo by 151.5% in the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after acquiring an additional 5,000 shares during the period. Marathon Capital Management grew its stake in shares of DocGo by 2.3% in the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock worth $856,000 after purchasing an additional 6,285 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in DocGo by 31.6% in the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after purchasing an additional 9,696 shares during the period. Nisa Investment Advisors LLC raised its position in DocGo by 693.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock worth $37,000 after purchasing an additional 10,565 shares during the last quarter. Finally, Gladius Capital Management LP acquired a new position in DocGo during the 2nd quarter worth about $34,000. Institutional investors own 56.44% of the company’s stock.

DocGo Price Performance

NASDAQ DCGO opened at $3.20 on Friday. The business has a fifty day moving average price of $3.45 and a two-hundred day moving average price of $3.36. The stock has a market capitalization of $327.42 million, a PE ratio of 11.43, a PEG ratio of 2.73 and a beta of 0.91. DocGo has a fifty-two week low of $2.75 and a fifty-two week high of $6.90.

DocGo (NASDAQ:DCGOGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). DocGo had a return on equity of 8.90% and a net margin of 3.97%. The business had revenue of $164.95 million for the quarter, compared to the consensus estimate of $166.61 million. As a group, sell-side analysts expect that DocGo will post 0.23 earnings per share for the current year.

DocGo Company Profile

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

See Also

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.